New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 15, 2014
07:39 EDTTEVATeva confident U.S. will soon approve new Copaxone, Reuters reports
Teva Pharmaceutical says it's "completely confident" the new version Copaxone, its main multiple sclerosis drug, which features less frequent dosing, will soon be approved in the U.S., reports Reuters. Teva's branded MS drug accounts for about 20% of sales and 50% of Teva profits.Reference Link
News For TEVA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 29, 2014
07:19 EDTTEVAUBS to hold a field trip
Subscribe for More Information
05:26 EDTTEVAProtalix appoints Moshe Manor as CEO
Subscribe for More Information
September 17, 2014
11:01 EDTTEVAActavis drops after NY AG seeks to block Alzheimer drug switch
Subscribe for More Information
08:05 EDTTEVAEagle Pharm says Teva requests motion to dismiss Bendamustine lawsuit
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use